Unknown

Dataset Information

0

Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes.


ABSTRACT: We designed a retrospective study to assess the surgical and economic outcomes of robot-assisted laparoscopic pyeloplasty (RALP) compared with open pyeloplasty (OP), including consecutive patients suffering from ureteropelvic junction obstruction and operated on from January 2012 to January 2022 at a single center. Preoperative, intraoperative, and postoperative outcomes, including costs, were comparatively analyzed. The primary outcome was 3-month success, defined as symptom resolution and no obstruction upon diuretic renal scintigraphy. Overall, 91 patients were included (48 OP and 43 RALP). The success rate at 3 months was 93.0% and 83.3% in the RALP and OP group, respectively (p = 0.178), and the results remained stable at the last follow-up (35.4 ± 22.8 months and 56.0 ± 28.1 months, respectively). Intraoperative blood loss (p < 0.001), need for postoperative analgesics (p = 0.019) and antibiotics (p = 0.004), and early postoperative complication rate (p = 0.009) were significantly lower in the RALP group. None of the assessed variables were a predictor for failure. The mean total direct cost per surgical procedure and related hospital stay was 2373 € higher in the RALP group. RALP is an effective and safe treatment for ureteropelvic junction obstruction; however, further studies are needed to evaluate the cost-effectiveness of RALP, accounting for indirect costs and cost-saving with new surgical platforms.

SUBMITTER: Moretto S 

PROVIDER: S-EPMC10095392 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


We designed a retrospective study to assess the surgical and economic outcomes of robot-assisted laparoscopic pyeloplasty (RALP) compared with open pyeloplasty (OP), including consecutive patients suffering from ureteropelvic junction obstruction and operated on from January 2012 to January 2022 at a single center. Preoperative, intraoperative, and postoperative outcomes, including costs, were comparatively analyzed. The primary outcome was 3-month success, defined as symptom resolution and no o  ...[more]

Similar Datasets

| S-EPMC5353856 | biostudies-literature
| S-EPMC10808368 | biostudies-literature
| S-EPMC8765333 | biostudies-literature
| S-EPMC9834369 | biostudies-literature
| S-EPMC10000228 | biostudies-literature
| S-EPMC6830494 | biostudies-literature
| S-EPMC11750000 | biostudies-literature
| S-EPMC8057975 | biostudies-literature
| S-EPMC9257661 | biostudies-literature